Gland Pharma

BSE : 543245 | NSE : GLAND
Industry : Pharma Drugs | ISIN : INE068V01023 | FreeFloat : 34.77% | FnO : No | LotSize : N/A
Intellectual Capital (IC)24,265.19
Net Worth (NW)7,157.62
Intrinsic Worth (IW)31,422.81
Market Cap (MC)53,770.53
Economic Value Added126.64
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)77.22%
IC Gross Margin (EBITDA/IC)7.43%
IC Net Margin (NPT/IC)5.16%
Knowledge Turnover (Sales/IC)0.19
Market to Intrinsic Value (MC/IW)1.71
As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 1,912.50Rs. 3,272.65
26 May 2022 ---- Rs. 2,852.00
108.75     3.81%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 2,993.77AccumulateBuy
KB > 50% : Yes50 DMA : Rs. 3,176.52
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
S
674.46
708.28
296.98
274.63
274.33
183.77
181.70
Sep-19
S
677.61
711.47
274.54
250.61
249.88
240.19
239.37
Dec-19
S
645.94
671.22
237.06
212.83
207.15
154.10
153.59
Mar-20
S
635.24
681.44
286.06
261.99
261.51
194.79
192.98
Jun-20
S
884.21
916.29
444.70
420.47
420.00
313.59
312.56
Sep-20
S
831.50
851.85
318.05
293.39
292.63
218.86
217.88
Dec-20
C
859.42
894.55
299.36
274.40
273.24
204.11
204.89
Mar-21
C
887.75
934.96
374.89
349.96
348.94
260.41
260.41
Jun-21
C
1153.90
1215.74
498.12
472.84
471.84
350.65
350.65
Sep-21
C
1080.47
1131.67
427.80
401.69
400.67
302.08
302.08
Dec-21
C
1063.33
1108.99
394.58
366.75
365.56
273.03
273.03
Mar-22
C
1103.01
1168.25
413.59
382.52
380.48
285.90
285.98
* C - Consolidated, S - Standalone